Dupilumab for Eosinophilic Esophagitis in Adolescents and Adults: Real-World Outcomes Across Different Dosing Regimens from the EoE CONNECT Registry

Thumbnail Image

Files

Dupilumab for Eosinophilic.pdf (891.72 KB)
Identifiers
URI: https://hdl.handle.net/11268/17262
DOI: 10.14309/ajg.0000000000004088

Publication date

2026

Authors

Laserna Mendieta, Emilio J.
Úbeda Vargas. Victoria
Amorena, Edurne
Savarino, Edoardo V.
Casabona Francés, Sergio

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

SDG

goal-3

Metrics

Google Scholar

Research Projects

Organizational Units

Journal Issue

Abstract

Real-world data on dupilumab for eosinophilic esophagitis (EoE), particularly regarding flexible dosing and fibrostenotic phenotypes, are scarce. Objective: To evaluate the effectiveness and safety of dupilumab in clinical practice using the EoE CONNECT registry.

Description

UNESCO Subjects

Tratamiento médico
Sistema digestivo
Efectos químicos

Keywords

Bibliographic reference

Laserna-Mendieta, E. J., Úbeda-Vargas, V., Amorena, E., Savarino, E. V., Casabona-Francés, S., Coletta, M., Molina-Infante, J., Pérez-Martínez, I., Rossi, C. M., Dilaghi, E., Guagnozzi, D., Blas-Jhon, L., Betoré, E., Fernández-Fernández, S., Naves, J. E., Roales, V., Piccirelli, S., Granja-Navacerrada, A., Honrubia-López, R., … Lucendo, A. J. (2026). Dupilumab for eosinophilic esophagitis in adolescents and adults: Real-world outcomes across different dosing regimens from the eoe connect registry. American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000004088
Editor's version
http://doi.org/10.14309/ajg.0000000000004088

Type of document

journal article

Collections

Área de Ciencias de la Salud
Attribution-NonCommercial-NoDerivatives 4.0 International

La licencia de este ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International